Primary hypomagnesemia with secondary hypocalcemia Advocacy Hub | UniteRare

At a Glance

Live from database

No FDA or trial events recorded yet for Primary hypomagnesemia with secondary hypocalcemia.

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Primary hypomagnesemia with secondary hypocalcemia.
Check the disease page for updates →

1 FDA-approved

IMPAVIDO

(miltefosine)Orphan drugstandard

Knight Therapeutics (USA)

Antileishmanial [EPC]

12.1 Mechanism of Action Miltefosine is an anti-leishmanial agent [see Clinical Pharmacology ( 12.4 )] .

No active clinical trials currently recruiting for Primary hypomagnesemia with secondary hypocalcemia.
Search all trials →

No recent news articles indexed yet for Primary hypomagnesemia with secondary hypocalcemia.
Search PubMed for Primary hypomagnesemia with secondary hypocalcemia →

No specialists currently listed for Primary hypomagnesemia with secondary hypocalcemia.

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants